Axitinib (AG-013736) as Second Line Therapy for Metastic

  • Jha, Gautam (PI)
  • Dudek, Arkadiusz Z (Prior Principal Investigator)

Project: Research project

Project Details

Description

A RANDOMIZED, OPEN-LABEL PHASE 3 STUDY OF AG-013736 VERSUS SORAFENIB IN PATIENTS WITH METASTATIC RENAL CELL CANCER FOLLOWING FAILURE OF ONE PRIOR THERAPY
StatusFinished
Effective start/end date3/12/086/30/14

Funding

  • PFIZER, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.